October 21, 2020
Sumathi Sivapalasingam, 1990 Watson Fellow, is medical lead on Regeneron's Ebola and COVID-19 therapeutics.
Sumathi is the senior medical director at Regeneron, a NY-based biotech firm. The FDA has recently approved of Regeneron's Ebola treatment, Inmazeb, which Sumathi led in her capacity as senior medical director of early clinical development and experimental sciences. Her Watson Fellowship focused on health care systems in India and Sri Lanka.